arrow
T

Thomas Jackson

University of Oxford
H指数:17
被引数:789

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia

现成的双CAR-iNKT细胞免疫疗法可清除髓内和软脑膜高风险KMT2A重排白血病

Blood
IF23.1
2025-09-040
OAAI
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients

增强子异质性在急性淋巴细胞白血病中驱动患者间差异基因表达

Blood
IF23.1
2025-07-310
OAAI
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALL

PROM1/CD133标记了KMT2A重排婴儿急性淋巴细胞白血病中的一种增殖性类干细胞blast群体。

2025-07-050
OAAI
Lead optimisation of OXS007417: in vivo PK profile and hERG liability modulation to optimise a small molecule differentiation agent for the potential treatment of acute myeloid leukaemia
2024-01-011
OAAI
Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines
2023-10-013
PRE
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
2021-11-2528
OAAI
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis
2021-02-0534
OAAI
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
LEUKEMIA
IF13.4
2020-04-0240
OAAI